• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 23-10-2025: Press Release

    23-10-2025 | 09:14 am

    Glenmark USA is launching Ropivacaine Hydrochloride Injection USP in November, a generic equivalent. The target market had ~$20.9 million (approx. 2.09 Cr) in annual sales, offering a new revenue stream for Glenmark's expanding injectable portfolio.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited